Oruka Therapeutics, Inc. ORKA Income taxes at U.S. statutory rate of 21%
Income taxes at U.S. statutory rate of 21% at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.
The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s income taxes at u.s. statutory rate of 21%.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s income taxes at U.S. statutory rate of 21%?
- Oruka Therapeutics, Inc. (ORKA) reported income taxes at U.S. statutory rate of 21% of 21% in Q4 2025.
- What does income taxes at U.S. statutory rate of 21% mean?
- The effective tax rate expressed as a percentage of pre-tax income, reconciled against the federal statutory tax rate. This metric helps investors identify how specific tax policies, credits, or jurisdictional differences influence the company's overall tax burden. It is a key measure for assessing the tax efficiency of the corporate structure.